Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

The Finviz API:   Higher Limits, Clearer Data, and More Ways to Connect

Get Started Now
Market News Market Pulse Stocks News ETF News Crypto News

Avalo Therapeutics

Contributing Author

Recent Articles by Avalo Therapeutics

Sep-29
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) AVTX GlobeNewswire
Sep-23
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress AVTX -7.33% GlobeNewswire
Sep-04
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) AVTX GlobeNewswire
Sep-03
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX GlobeNewswire
Aug-06
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates AVTX GlobeNewswire
Jul-22
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference AVTX GlobeNewswire
Jul-07
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum AVTX GlobeNewswire
Jun-26
Avalo Therapeutics to Join the Russell 2000 and Russell 3000 Indexes AVTX GlobeNewswire
Jun-23
Avalo Therapeutics Appoints Ron Philip to Board of Directors AVTX GlobeNewswire
Jun-16
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody AVTX GlobeNewswire
May-22
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) AVTX GlobeNewswire
May-13
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates AVTX GlobeNewswire
May-05
Avalo Therapeutics Announces Pricing of $375 Million Public Offering AVTX +34.13% GlobeNewswire
May-05
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants AVTX +18.00% AVTX +34.13% GlobeNewswire
May-05
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa AVTX +18.00% AVTX +34.13% GlobeNewswire
Apr-28
Avalo Therapeutics Purchases Optional Milestone Buyout AVTX -10.82% GlobeNewswire
Mar-23
Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates AVTX GlobeNewswire
Feb-24
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX +9.46% GlobeNewswire
Feb-18
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) AVTX AVTX +6.47% GlobeNewswire
Feb-04
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX -9.96% GlobeNewswire
Nov-17
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) AVTX +11.68% AVTX +6.67% GlobeNewswire
Nov-06
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates AVTX -6.26% GlobeNewswire
Nov-03
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX -7.54% GlobeNewswire
Oct-29
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa AVTX GlobeNewswire
Oct-01
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources AVTX GlobeNewswire
Sep-22
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors AVTX GlobeNewswire
Aug-27
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX GlobeNewswire
Aug-07
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates AVTX GlobeNewswire
Jun-23
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX GlobeNewswire
Jun-18
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors AVTX +6.49% GlobeNewswire
May-27
Avalo Therapeutics to Participate in Upcoming Investor Conferences AVTX GlobeNewswire
May-12
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates AVTX GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)